The dose-independent secretion of IL-1β at 24 h p.i. by infected mouse macrophages suggests that inflammasomes responsible for recognizing these intracellular bacteria at the late stage of infection are very sensitive to the activation of ligand(s) generated during rickettsial infection, and could be an ideal candidate for vaccine development targeting inflammasome activation in the future. Here, IL1B is linked to infection.